Literature DB >> 10799444

Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system. The NIAID DAIDS New Technologies Evaluation Group.

K A Reimann1, M R O'Gorman, J Spritzler, C L Wilkening, D E Sabath, K Helm, D E Campbell.   

Abstract

New analytic methods that permit absolute CD4 and CD8 T-cell determinations to be performed entirely on the flow cytometer have the potential for improving assay precision and accuracy. In a multisite trial, we compared two different single-platform assay methods with a predicate two-color assay in which the absolute lymphocyte count was derived by conventional hematology. A two-color method employing lymphocyte light scatter gating and Beckman Coulter Flow-Count fluorospheres for absolute counting produced within-laboratory precision equivalent to that of the two-color predicate method, as measured by coefficient of variation of replicate measurements. The fully automated Beckman Coulter tetraONE System four-color assay employing CD45 lymphocyte gating, automated analysis, and absolute counting by fluorospheres resulted in a small but significant improvement in the within-laboratory precision of CD4 and CD8 cell counts and percentages suggesting that the CD45 lymphocyte gating and automated analysis might have contributed to the improved performance. Both the two-color method employing Flow-Count fluorospheres and the four-color tetraONE System provided significant and substantial improvements in between-laboratory precision of absolute counts. In some laboratories, absolute counts obtained by the single-platform methods showed small but consistent differences relative to the predicate method. Comparison of each laboratory's absolute counts with the five-laboratory median value suggested that these differences resulted from a bias in the absolute lymphocyte count obtained from the hematology instrument in some laboratories. These results demonstrate the potential for single-platform assay methods to improve within-laboratory and between-laboratory precision of CD4 and CD8 T-cell determinations compared with conventional assay methods.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799444      PMCID: PMC95877          DOI: 10.1128/CDLI.7.3.344-351.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  19 in total

1.  Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Site Investigators and The NIAID DAIDS New Technologies Evaluation Group.

Authors:  C T Schnizlein-Bick; J Spritzler; C L Wilkening; J K Nicholson; M R O'Gorman
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

2.  Effect of type of haematology analyser on CD4 count.

Authors:  G Robinson; L Morgan; M Evans; S McDermott; S Pereira; M Wansbrough-Jones; G Griffin
Journal:  Lancet       Date:  1992-08-22       Impact factor: 79.321

3.  Consistency of routine measurements of CD4+, CD8+ peripheral blood lymphocytes.

Authors:  J P Aboulker; B Autran; K Beldjord; F Touraine; P Debre
Journal:  J Immunol Methods       Date:  1992-10-02       Impact factor: 2.303

Review 4.  EDTA, the traditional anticoagulant of haematology: with increased automation is it time for a review?

Authors:  D M Reardon; B Warner; E A Trowbridge
Journal:  Med Lab Sci       Date:  1991-01

Review 5.  The pathobiology of HIV infection. A review.

Authors:  R D Smith
Journal:  Arch Pathol Lab Med       Date:  1990-03       Impact factor: 5.534

6.  Quantitation of cell concentration using the flow cytometer.

Authors:  C C Stewart; J A Steinkamp
Journal:  Cytometry       Date:  1982-01

7.  Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.

Authors:  H N Ho; L E Hultin; R T Mitsuyasu; J L Matud; M A Hausner; D Bockstoce; C C Chou; S O'Rourke; J M Taylor; J V Giorgi
Journal:  J Immunol       Date:  1993-04-01       Impact factor: 5.422

Review 8.  CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review.

Authors:  D S Stein; J A Korvick; S H Vermund
Journal:  J Infect Dis       Date:  1992-02       Impact factor: 5.226

9.  HIV-specific cytotoxic T lymphocytes in seropositive individuals.

Authors:  B D Walker; S Chakrabarti; B Moss; T J Paradis; T Flynn; A G Durno; R S Blumberg; J C Kaplan; M S Hirsch; R T Schooley
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

10.  Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group.

Authors:  J V Giorgi; H L Cheng; J B Margolick; K D Bauer; J Ferbas; M Waxdal; I Schmid; L E Hultin; A L Jackson; L Park
Journal:  Clin Immunol Immunopathol       Date:  1990-05
View more
  26 in total

Review 1.  Adoption of single-platform technologies for enumeration of absolute T-lymphocyte subsets in peripheral blood.

Authors:  M R O'Gorman; J K Nicholson
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

2.  Affordable CD4(+)-T-cell counting by flow cytometry: CD45 gating for volumetric analysis.

Authors:  George Janossy; Ilesh V Jani; Nicholas J Bradley; Arsene Bikoue; Tim Pitfield; Debbie K Glencross
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

3.  Comparison of a new, affordable flow cytometric method and the manual magnetic bead technique for CD4 T-lymphocyte counting in a northern Nigerian setting.

Authors:  Godwin E Imade; Bitrus Badung; Sunday Pam; Oche Agbaji; Daniel Egah; Atiene S Sagay; Jean-Louis Sankalé; Saidi Kapiga; John Idoko; Phyllis Kanki
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

4.  ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3- NK cells.

Authors:  U Koehl; K Bochennek; R Esser; A Brinkmann; R Quaritsch; M Becker; J Soerensen; P Bader; D Schwabe; T Klingebiel; J Fischer; S Y Zimmermann
Journal:  Int J Hematol       Date:  2007-12-18       Impact factor: 2.490

5.  Evaluation of a single-platform technology for lymphocyte immunophenotyping.

Authors:  Jeanette Higgins; Valerie Hill; Karen Lau; Virginia Simpson; Jean Roayaei; Rick Klabansky; Randy A Stevens; Julia A Metcalf; Michael Baseler
Journal:  Clin Vaccine Immunol       Date:  2007-08-29

6.  Optimization of a highly standardized carboxyfluorescein succinimidyl ester flow cytometry panel and gating strategy design using discriminative information measure evaluation.

Authors:  Cliburn Chan; Lin Lin; Jacob Frelinger; Valérie Hérbert; Dominic Gagnon; Claire Landry; Rafick-Pierre Sékaly; Jennifer Enzor; Janet Staats; Kent J Weinhold; Maria Jaimes; Mike West
Journal:  Cytometry A       Date:  2010-12       Impact factor: 4.355

7.  Optimized protocols for isolation, fixation, and flow cytometric characterization of leukocytes in ischemic hearts.

Authors:  Roman Covarrubias; Mohamed Ameen Ismahil; Gregg Rokosh; Tariq Hamid; Federica Accornero; Harpreet Singh; Richard J Gumina; Sumanth D Prabhu; Shyam S Bansal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-02       Impact factor: 4.733

Review 8.  Diagnosis of Human Immunodeficiency Virus Infection.

Authors:  Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

Review 9.  Modeling flow cytometry data for cancer vaccine immune monitoring.

Authors:  Jacob Frelinger; Janet Ottinger; Cécile Gouttefangeas; Cliburn Chan
Journal:  Cancer Immunol Immunother       Date:  2010-06-19       Impact factor: 6.968

10.  Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity.

Authors:  Eric Toussirot; Philippe Saas; Marina Deschamps; Fabienne Pouthier; Lucille Perrot; Sylvain Perruche; Jacqueline Chabod; Pierre Tiberghien; Daniel Wendling
Journal:  Arthritis Res Ther       Date:  2009-07-01       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.